Anti-Inflammatory Activity of Traditional Instant Parem From Usada Bali on Carrageenan-Induced Inflammatory Mice Model

Authors

  • Putu Era Sandhi Kusuma Yuda Fakultas Farmasi, Universitas Mahasaraswati Denpasar
  • Gusti Ayu Putu Yosinta Sasmita Fakultas Farmasi, Universitas Mahasaraswati Denpasar ,
  • Erna Cahyaningsih Fakultas Farmasi, Universitas Mahasaraswati Denpasar ,

DOI:

https://doi.org/10.35814/jifi.v20i2.1076

Keywords:

Balinese Usada, inflammation, instant parem, jamu, traditional medicine

Abstract

The increase of adverse reactions from anti-inflammatory drugs that are used in the long term by rheumatic patients requires a relatively safer alternative therapy. This research was aimed to evaluate the effectiveness of Usada Bali's instant parem (BIO-PAREM) as an anti-inflammatory agent against carrageenan-induced inflammatory mice. The method used was randomized pre-test and post-test with control group design using 24 mice which were divided into 4 treatment groups. The negative control group was given a vehicle, the positive control group was given anti-inflammatory gel of diclofenac sodium, group 3 (P1) was given BIO-PAREM with a concentration of 12.5% and group 4 (P2) was given BIO-PAREM with a concentration of 25%. All groups were induced with 1% carrageenan, then the mice's paw edema volume was calculated using a plethysmometer at 0, 1, 2, 3, and 4 hours. The Kruskal Wallis and Mann Whitney test were used to analyse the relative change of inflammation volume. The BIO-PAREM phytochemical screening assay showed the presence of alkaloids, flavonoids, tannins, steroids and triterpenoids. BIO-PAREM showed significant inhibition of mice's paw edema at concentrations of 12.5% and 25% (p <0.05) indicating its potential as a candidate for topical alternative treatment for rheumatism.

References

Downloads

Published

2022-10-30

Issue

Vol. 20 No. 2 (2022): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.